These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19962578)

  • 1. Guidelines for the use of immunoglobulin therapy for primary immune deficiency and solid organ transplantation.
    Nahirniak S; Hume HA
    Transfus Med Rev; 2010 Jan; 24 Suppl 1():S1-6. PubMed ID: 19962578
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.
    Shehata N; Palda VA; Meyer RM; Blydt-Hansen TD; Campbell P; Cardella C; Martin S; Nickerson P; Peltekian K; Ross H; Waddell TK; West L; Anderson D; Freedman J; Hume H
    Transfus Med Rev; 2010 Jan; 24 Suppl 1():S7-S27. PubMed ID: 19962580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications and safety of intravenous and subcutaneous immunoglobulin therapy.
    Rezaei N; Abolhassani H; Aghamohammadi A; Ochs HD
    Expert Rev Clin Immunol; 2011 May; 7(3):301-16. PubMed ID: 21595597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline.
    Shehata N; Palda V; Bowen T; Haddad E; Issekutz TB; Mazer B; Schellenberg R; Warrington R; Easton D; Anderson D; Hume H
    Transfus Med Rev; 2010 Jan; 24 Suppl 1():S28-50. PubMed ID: 19962579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogammaglobulinemia and infection risk in solid organ transplant recipients.
    Mawhorter S; Yamani MH
    Curr Opin Organ Transplant; 2008 Dec; 13(6):581-5. PubMed ID: 19060546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended indications for the administration of polyclonal immunoglobulin preparations.
    Delforge M; Farber CM; Spath P; Kaveri S; Witte T; Misbah SA; Hübner R; Haerynck F; Latinne D; Muylle L; Toungouz M; Deneys V;
    Acta Clin Belg; 2011; 66(5):346-60. PubMed ID: 22145269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose intravenous immunoglobulin treatment: mechanisms of action.
    Boros P; Gondolesi G; Bromberg JS
    Liver Transpl; 2005 Dec; 11(12):1469-80. PubMed ID: 16315304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The patient: Emerging clinical applications of intravenous immunoglobulin.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin therapy: the process, the product, the patient, and the pocketbook. Introduction.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):71S-72S. PubMed ID: 16229676
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoglobulin therapy: methods of delivery.
    Ballow M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
    [No Abstract]   [Full Text] [Related]  

  • 11. Giving intravenous immunoglobulin.
    Scherf R; White-Reid K
    RN; 2008 Jan; 71(1):29-34; quiz 35. PubMed ID: 18271361
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of certain immune deficient peripheral neuropathies with intravenous immunoglobulins].
    Pouget J
    Rev Prat; 1994 Nov; 44(18):2404-6. PubMed ID: 7855497
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
    Cooper N
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1317-27. PubMed ID: 19932436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The new domestic immunoglobulin G gabriglobin in complex therapy of immunodeficiency states and infectious pathology].
    Pas'ko VG; Latysheva TV; Nikiforov VV; Mostovskaia EV; Denisov AK; Kondrashin IuI
    Voen Med Zh; 2006 Jul; 327(7):40-2. PubMed ID: 16977880
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of intravenous immunoglobulin in neurological disorders].
    Steck AJ
    Rev Med Suisse; 2005 Apr; 1(17):1167-70. PubMed ID: 15941089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of suspected immune deficiency by the primary care physician.
    Infante AJ; Kamani NR
    Compr Ther; 1997 Feb; 23(2):89-94. PubMed ID: 9083718
    [No Abstract]   [Full Text] [Related]  

  • 17. West Nile virus encephalitis in a renal transplant recipient: the role of intravenous immunoglobulin.
    Saquib R; Randall H; Chandrakantan A; Spak CW; Barri YM
    Am J Kidney Dis; 2008 Nov; 52(5):e19-21. PubMed ID: 18676077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin.
    Körber A; Franckson T; Grabbe S; Dissemond J
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):553-4. PubMed ID: 17373996
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
    Galdos M; Etxebarría J
    Cornea; 2008 Sep; 27(8):967-9. PubMed ID: 18724167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy recommendations for the use of intravenously applicable immunoglobulins].
    Marschner JP; Rietbrock N
    Med Klin (Munich); 1996 Mar; 91(3):141-7. PubMed ID: 8628200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.